Status:
COMPLETED
An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
Brief Summary
The purpose of the study is to collect data of patients who were randomized (assignment of study medication by chance) and treated in 3 previous studies of galantamine (CR003145, CR002014 and CR005947...
Detailed Description
The objective of this observational study is to ascertain follow-up vital status data for patients who were randomized (assignment of study medication by chance) and treated with galantamine or placeb...
Eligibility Criteria
Inclusion
- All patients who were randomized and treated with galantamine or placebo in 3 previous studies (CR003145, CR002014, and CR005947)
Exclusion
- Patients not enrolled in above referenced studies
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
1083 Patients enrolled
Trial Details
Trial ID
NCT00297414
Start Date
June 1 2004
End Date
January 1 2005
Last Update
April 12 2012
Active Locations (144)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson, Arizona, United States
2
Laguna Woods, California, United States
3
Northridge, California, United States
4
Oceanside, California, United States